D47.09
Other mast cell neoplasms of uncertain behavior
Clinical Classification Guidelines
Inclusion Terms
- Extracutaneous mastocytoma
- Mast cell tumor NOS
- Mastocytoma NOS
- Mastocytosis NOS
Medical Intelligence & Overview
ICD-10 code D47.09 refers to a category of rare conditions involving abnormal growths of mast cells that have uncertain behavior. These conditions can occur outside the skin (extracutaneous) and are collectively known as mast cell neoplasms. Mast cells are part of the immune system and play a role in allergic reactions and inflammation. When they grow abnormally in certain tissues, it can lead to complex health issues. Conditions falling under this code include extrachutaneous mastocytoma and various types of mast cell tumors or mastocytosis that are not clearly benign or malignant.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting mast cell development Unknown specific triggers, as these neoplasms are rare Potential associations with other blood disorders or genetic syndromes
Key Symptoms: Swelling or lumps in affected tissues Skin symptoms such as flushing, itching, or hives (if skin involved) Abdominal pain, nausea, or diarrhea due to release of mast cell mediators Difficulty breathing or wheezing in severe cases Unexplained fatigue or weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. A biopsy of the affected tissue is often necessary to confirm the presence of abnormal mast cells. Imaging studies such as CT scans or MRIs may be used to assess the extent and location of growths. Laboratory tests may include blood work to identify elevated levels of tryptase, a marker of mast cell activation. It's important to differentiate these neoplasms from other tumors or inflammatory conditions through detailed histopathological analysis.
Treatment Protocols: Medications such as antihistamines and leukotriene antagonists to control allergic symptoms Targeted therapies focusing on mast cell stabilization or growth inhibition Surgical removal of localized tumors if feasible Chemotherapy or radiation in cases with more aggressive disease Monitoring and supportive care to address complications
Clinical Advice & FAQs
Billing Guidance
Is D47.09 a billable ICD-10 code?
Yes, D47.09 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D47.09?
Clinical documentation must specify the nature of Other mast cell neoplasms of uncertain behavior and any associated comorbidities for accurate reporting.
Cite this Clinical Reference